Use of polymyxin as an endotoxin blocker in the prevention of diffuse lamellar keratitis in an animal model

Journal of Refractive Surgery

Volumn 21, Issue 2, 2005, Pages 152-157

  Morck, Douglas W ^a   Holland, Simon P ^b,c   Ceri, Howard ^a   Hancock, Robert ^b   Scott Gough, Monisha ^b   Nugyen, Van ^a   Keith, Erin J ^b,c   Lee, Tracy L ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Pacific Laser Eye Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BALANCED SALT SOLUTION; ENDOTOXIN; EYE DROPS; POLYMYXIN; POLYTRIM;

ANIMAL MODEL; ARTICLE; BURKHOLDERIA CEPACIA; CELL INFILTRATION; DIFFUSE LAMELLAR KERATITIS; INFLAMMATION; KERATOMILEUSIS; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RABBIT; TISSUE FLAP;

EID: 15544364943     PISSN: 1081597X     EISSN: None     Source Type: Journal    
DOI: 10.3928/1081-597x-20050301-10     Document Type: Article

References (14)

1. Smith RJ, Maloney RK. Diffuse lamellar keratitis. A new syndrome in lamellar refractive surgery. Ophthalmology. 1998;105:1721-1726.
2. Alio JL, Perez-Santonja JJ, Tervo T, Tabbara KF, Vesaluoma M, Smith RJ, Maddox B, Maloney RK. Postoperative inflammation, microbial complications and wound healing following laser is situ keratomileusis. J Refract Surg. 2000;16:523-538.
3. Holland SP. Update in cornea and external disease: solving the mystery of "sands of the Sahara" syndrome (diffuse lamellar keratitis). Can J Ophthalmol. 1999;34:193-194.
4. Holland SP, Mathias RG, Morck DW, Chiu J, Slade SG. Diffuse lamellar, keratitis related to endotoxins released from sterilizer reservoir biofilms. Ophthalmology. 2000;107:1227-1233.
5. Gough M, Hancock RE, Kelly NM. Antiendotoxin activity of cationic peptide antimicrobial agents. Infect Immun. 1996;64:4922-4927.
6. Schultz CL, Buret AG, Olson ME, Ceri H, Read RR, Morck DW. Lipopolysaccharide entry in the damaged cornea and specific uptake by polymorphonuclear neutrophils. Infect Immun. 2000;68:1731-1734.
7. Holland SP, Morck D, Mathias R, Lee T, Keith E. Success and failure in resolving outbreak DLK: a multiple clinic review. Paper presented at: American Society of Cataract and Refractive Surgery annual meeting; April 12-16, 2003; San Francisco, Calif.
8. Pristovsek P, Kidric J. Solution structure of polymyxins B and E and effect of binding to lipopolysaccharide: an NMR and molecular modeling study. J Med Chem. 1999;42:4604-4613.
9. Olfert ED, Cross BM, McWilliam AA, eds. Canadian Council on Animal Care Guidelines for the Care and Use of Experimental Animals. Vol 1. 2nd ed. Ottawa, Ontario: Bradda Printing Services Inc; 1993.
10. Peters NT, Iskander NG, Anderson Penno EE, Woods DE, Moore RA, Gimbel HV. Diffuse lamellar keratitis: isolation of endotoxin and demonstration of inflammatory potential in rabbit laser in situ keratomileusis model. J Cataract Refract Surg. 2001;27:917-923.
11. Zhang L, Dhillon P, Yan H, Farmer S, Hancock RE. Interactions of bacterial cationic peptide antibodies with outer and cytoplasmic membranes of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2000;44:3317-3321.
12. Peters NT, Anderson Penno EE, Iskander NG, Gimbel HV. Endotoxin induced epidemic diffuse lamellar keratitis: inflammatory potential and treatment options. Poster presented at: American Academy of Ophthalmology annual meeting; October 20-24, 2000; Dallas, Tex.
13. Holland SP. Success and failure in resolving an outbreak of diffuse lamellar keratitis: a review of 44 outbreaks. Paper presented at: American Society of Cataract and Refractive Surgery Symposium on Cataract, IOL and Refractive Surgery; April 12-16, 2003; San Francisco, Calif.
14. Peters NT, Lingua RW, Kim CH. Topical intrastromal steroid during laser in situ keratomileusis to retard interface keratitis. J Cataract Refract Surg. 1999;25:1437-1440.